foxo4-dri patent — ≥99% Purity, COA Included Peptide inhibitors targeting FOXO4-p53 interactions
Peptide inhibitors targeting FOXO4 p53 interactions and inducing senescent cancer cell specific apoptosis bioRxiv FOXO4 DRI: Human Trial Status, Cancer Research & Senolytic Data Buy FOXO4 DRI (Proxofim) Senolytic Peptide For Cellular Renewal FOX04 DRI (10mg) Nordsci
Pay in 4 interest-free payments of $6.88 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18



